Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
15 March 2018Website:
http://www.n1mtc.comNext earnings report:
13 December 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Thu, 14 Nov 2024 21:36:42 GMTDividend
Analysts recommendations
Institutional Ownership
NMTC Latest News
License Provides Exclusive Commercialization Rights for US Distribution and Certain OUS MarketsAgreement expected to boost NeuroOne sales revenue and profitability
Forty-four ablations performed successfully in one patient Patient currently reportedly seizure free with improvements in mood and memory EDEN PRAIRIE, Minn., Sept. 10, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that the OneRF Ablation System was recently used in a breakthrough patient procedure at the University Hospitals in Cleveland to successfully complete forty four ablations in one patient.
EDEN PRAIRIE, Minn., Aug. 12, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will host a conference call and webcast on August 14, 2024, at 4:30 PM Eastern Time to discuss financial results for its third quarter of fiscal year 2024 ended June 30, 2024, and provide a corporate update.
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) will hold its Q2 2024 Earnings Conference Call on May 14, 2024 at 4:30 PM ET. Presenting will be Dave Rosa, President & CEO, and Ron McClurg, CFO. Welcome to the NeuroOne Medical Technologies Corporation Second Quarter of Fiscal Year 2024 Financial Results Conference Call.
NeuroOne Medical Technologies Corporation (NMTC) Q1 2024 Earnings Call Transcript
EDEN PRAIRIE, Minn., Feb. 08, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will host a conference call and webcast on February 13, 2024 at 4:30 PM Eastern Time to discuss financial results for its first quarter of fiscal year 2024 ended December 31, 2023, and provide a corporate update.
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC ) Q3 2023 Results Conference Call August 14, 2023 4:30 PM ET Company Participants Dave Rosa - Chief Executive Officer Ron McClurg - Chief Financial Officer Operator Good day, ladies and gentlemen. Thank you for standing by.
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC ) Q2 2023 Earnings Conference Call May 11, 2023 4:30 PM ET Company Participants Dave Rosa - Chief Executive Officer Ron McClurg - Chief Financial Officer Conference Call Participants Ben Haynor - Alliance Global Partners Operator Ladies and gentlemen, thank you for standing by. And welcome to the NeuroOne Medical Technologies Corporation Second Quarter Fiscal Year 2023 Financial Results Conference Call.
EDEN PRAIRIE, Minn., May 11, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will host a conference call to discuss financial results for its fiscal second quarter 2023 ended March 31, 2023 and provide a corporate update on May 11, 2023 at 4:30 PM Eastern Time.
What type of business is NeuroOne Medical Technologies?
NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.
What sector is NeuroOne Medical Technologies in?
NeuroOne Medical Technologies is in the Healthcare sector
What industry is NeuroOne Medical Technologies in?
NeuroOne Medical Technologies is in the Medical Devices industry
What country is NeuroOne Medical Technologies from?
NeuroOne Medical Technologies is headquartered in United States
When did NeuroOne Medical Technologies go public?
NeuroOne Medical Technologies initial public offering (IPO) was on 15 March 2018
What is NeuroOne Medical Technologies website?
https://www.n1mtc.com
Is NeuroOne Medical Technologies in the S&P 500?
No, NeuroOne Medical Technologies is not included in the S&P 500 index
Is NeuroOne Medical Technologies in the NASDAQ 100?
No, NeuroOne Medical Technologies is not included in the NASDAQ 100 index
Is NeuroOne Medical Technologies in the Dow Jones?
No, NeuroOne Medical Technologies is not included in the Dow Jones index
When was NeuroOne Medical Technologies the previous earnings report?
No data
When does NeuroOne Medical Technologies earnings report?
The next expected earnings date for NeuroOne Medical Technologies is 13 December 2024